Voluven is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira Inc.. The primary component is Hydroxyethyl Starch 130/0.4.
Product ID | 0409-1029_4cf79958-bba6-4ab0-b970-92b80ce04439 |
NDC | 0409-1029 |
Product Type | Human Prescription Drug |
Proprietary Name | Voluven |
Generic Name | Hydroxyethyl Starch 130/0.4 |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-06-25 |
Marketing Category | NDA / NDA |
Application Number | BN070012 |
Labeler Name | Hospira Inc. |
Substance Name | HYDROXYETHYL STARCH 130/0.4 |
Active Ingredient Strength | 6 g/100mL |
Pharm Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2010-06-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | BN070012 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-11-07 |
Marketing End Date | 2020-02-28 |
Marketing Category | NDA |
Application Number | BN070012 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-06-25 |
Marketing End Date | 2020-02-28 |
Marketing Category | NDA |
Application Number | BN070012 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2012-03-15 |
Marketing End Date | 2020-02-28 |
Ingredient | Strength |
---|---|
HYDROXYETHYL STARCH 130/0.4 | 6 g/100mL |
SPL SET ID: | c2c45e02-5d9a-4a54-f291-e5b54671b08b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VOLUVEN 75921641 2497816 Live/Registered |
FRESENIUS SE & CO. KGAA 2000-02-16 |